aHR	Adjusted hazard ratio
ART	Assisted reproductive technology
BRCA1/2	Breast cancer gene 1/2
CA-125	Cancer antigen 125
CI	Confidence interval
DE	Deep endometriosis
DNA	Deoxyribonucleic acid
EAOC	Endometriosis-associated ovarian cancer
ESGO	European Society of Gynaecological Oncology
FIGO	International Federation of Gynecology and Obstetrics
GPX4	Glutathione peroxidase 4
GSH	Glutathione
HE4	Human epididymis protein 4
HGSOC	High-grade serous ovarian carcinoma
HIF-1α	Hypoxia-inducible factor 1α
HNF-1β	Hepatocyte nuclear factor 1β
HR	Hazard ratio
JAMA	Journal of the American Medical Association
MAPK	Mitogen-activated protein kinase
miRNA	MicroRNA
MMR	Mismatch repair
MMRd	Mismatch repair deficiency
MRI	Magnetic resonance imaging
NRF2	Nuclear factor erythroid 2-related factor 2
OR	Odds ratio
OS	Overall survival
PI3K/AKT/mTOR	Phosphoinositide 3-kinase/AKT/mechanistic target of rapamycin pathway
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
ROMA	Risk of Ovarian Malignancy Algorithm
ROS	Reactive oxygen species
SIR	Standardized incidence ratio
SLC7A11	Solute carrier family 7 member 11
SWI/SNF	SWItch/Sucrose Non-Fermentable chromatin remodeling complex
TCGA	The Cancer Genome Atlas
UCEC	Uterine corpus endometrial carcinoma